- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01727284
MR-Guided Cryoablation of Prostate Bed Recurrences
September 3, 2025 updated by: David A. Woodrum, Mayo Clinic
Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences
The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
107
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa
- Surgery is not a desirable alternative therapy at the time of enrollment
- Radiation therapy has failed or not indicated or can be safely postponed
- Tumor size is < 5 cm at its largest diameter
- Tumor does not encompass the rectal wall or external urethral sphincter
- Patient is able to undergo MRI
Exclusion Criteria:
- N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MR-guided cryoablation (freezing of tissue and/or tumors)
Patients undergo cryoablation using the Galil MR-compatible cryoablation system and MRI while on study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evaluation of target lesion at 3-6, 12, 24, and 36 month imaging follow-up
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Woodrum, MD, PhD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 12, 2012
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Study Registration Dates
First Submitted
November 12, 2012
First Submitted That Met QC Criteria
November 14, 2012
First Posted (Estimated)
November 15, 2012
Study Record Updates
Last Update Posted (Estimated)
September 4, 2025
Last Update Submitted That Met QC Criteria
September 3, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-002245
- NCI-2023-01699 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Tumors
-
Istituto Romagnolo per lo Studio dei Tumori Dino...CompletedProstate-specific Membrane Antigen | mCRPC or Advanced/Metastatic Solid TumorsItaly
-
University of Michigan Rogel Cancer CenterMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkActive, not recruitingNeuroendocrine Tumors | Prostate Cancer MetastaticUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Prostate Small Cell Neuroendocrine Carcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
Fred Hutchinson Cancer CenterBristol-Myers SquibbWithdrawnStage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage III Prostate Cancer AJCC v8 | Prostate Small Cell Neuroendocrine CarcinomaUnited States
-
University of UtahNational Cancer Institute (NCI); MultiFunctional Imaging LLCCompleted
-
Mayo ClinicWithdrawn
-
Thomas HopeAbdera Therapeutics Inc.WithdrawnSolid Tumor Cancer | Castration Resistant Prostate Cancer | Castration Resistant Prostate Cancer (CRPC) | Neuroendocrine (NE) TumorsUnited States
-
Seoul National University HospitalUnknownProstate Cancer | Bladder Cancer | Bladder Tumor | Prostate Tumor
-
Sichuan Huiyang Life Science and Technology CorporationMedelis Inc.TerminatedMalignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine TumorUnited States
Clinical Trials on MR-guided cryoablation
-
Mayo ClinicRecruitingPrimary Malignant Neoplasm of Prostate (Diagnosis)United States
-
University of California, San FranciscoCompletedUterine FibroidsUnited States
-
Xi JunjieNot yet recruitingEarly Lung CancerChina
-
University Hospital HeidelbergLudwig-Maximilians - University of Munich; University Hospital, ZürichActive, not recruitingProstate CancerGermany
-
Brahms AGCompletedPatients Presenting With Suspicion of Infection to the EDSpain
-
Clinica Universidad de Navarra, Universidad de...Not yet recruiting
-
Clinica Universidad de Navarra, Universidad de...Not yet recruiting
-
Universitair Ziekenhuis BrusselRecruiting
-
Clinica Universidad de Navarra, Universidad de...Not yet recruitingProstate Cancer
-
UMC UtrechtRadboud University Medical Center; Catharina Ziekenhuis Eindhoven; Amsterdam... and other collaboratorsNot yet recruitingLocally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy (LAPSTAR)Locally Advanced Pancreatic AdenocarcinomaNetherlands